Galecto IPF Phase IIb trial goes full steam ahead

Galecto has recruited more than 150 patients to date for its Phase IIb GALACTIC-1 study of GB0139 for idiopathic pulmonary fibrosis (IPF). Credit: zlikovec / Shutterstock.



  • Galecto